-
1
-
-
0032713075
-
Safety and antitumor activity of recombinant soluble Apo2 ligand
-
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162.
-
(1999)
J Clin Invest
, vol.104
, pp. 155-162
-
-
Ashkenazi, A.1
Pai, R.C.2
Fong, S.3
Leung, S.4
Lawrence, D.A.5
Marsters, S.A.6
Blackie, C.7
Chang, L.8
McMurtrey, A.E.9
Hebert, A.10
DeForge, L.11
Koumenis, I.L.12
Lewis, D.13
Harris, L.14
Bussiere, J.15
Koeppen, H.16
Shahrokh, Z.17
Schwall, R.H.18
-
2
-
-
0030774216
-
Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination
-
Bramson JL, Hitt M, Gauldie J, Graham FL (1997) Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 4: 1069-1076.
-
(1997)
Gene Ther
, vol.4
, pp. 1069-1076
-
-
Bramson, J.L.1
Hitt, M.2
Gauldie, J.3
Graham, F.L.4
-
3
-
-
2542610615
-
Tissue distribution of the death ligand TRAIL and its receptors
-
Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, Hollema H, de Jong S (2004) Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem 52: 821-831.
-
(2004)
J Histochem Cytochem
, vol.52
, pp. 821-831
-
-
Spierings, D.C.1
de Vries, E.G.2
Vellenga, E.3
van den Heuvel, F.A.4
Koornstra, J.J.5
Wesseling, J.6
Hollema, H.7
de Jong, S.8
-
4
-
-
0043130148
-
Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene
-
Huang X, Lin T, Gu J, Zhang L, Roth JA, Liu J, Fang B (2003) Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene. Int J Oncol 22: 1241-1245.
-
(2003)
Int J Oncol
, vol.22
, pp. 1241-1245
-
-
Huang, X.1
Lin, T.2
Gu, J.3
Zhang, L.4
Roth, J.A.5
Liu, J.6
Fang, B.7
-
5
-
-
17944376030
-
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
-
Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP, Zhou T (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7: 954-960.
-
(2001)
Nat Med
, vol.7
, pp. 954-960
-
-
Ichikawa, K.1
Liu, W.2
Zhao, L.3
Wang, Z.4
Liu, D.5
Ohtsuka, T.6
Zhang, H.7
Mountz, J.D.8
Koopman, W.J.9
Kimberly, R.P.10
Zhou, T.11
-
6
-
-
0038826537
-
Safety of interleukin-12 gene therapy against cancer: A murine biodistribution and toxicity study
-
Imboden M, Shi F, Pugh TD (2003) Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study. Hum Gene Ther 14: 1037-1048.
-
(2003)
Hum Gene Ther
, vol.14
, pp. 1037-1048
-
-
Imboden, M.1
Shi, F.2
Pugh, T.D.3
-
7
-
-
0034022160
-
Apoptosis induced in normal human hepatocytes by tumor necrosis factor related apoptosis-inducing ligand
-
Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor related apoptosis-inducing ligand. Nat Med 6: 564-567.
-
(2000)
Nat Med
, vol.6
, pp. 564-567
-
-
Jo, M.1
Kim, T.H.2
Seol, D.W.3
Esplen, J.E.4
Dorko, K.5
Billiar, T.R.6
Strom, S.C.7
-
8
-
-
0035870294
-
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene
-
Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B (2001) Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61: 3330-3338.
-
(2001)
Cancer Res
, vol.61
, pp. 3330-3338
-
-
Kagawa, S.1
He, C.2
Gu, J.3
Koch, P.4
Rha, S.J.5
Roth, J.A.6
Curley, S.A.7
Stephens, L.C.8
Fang, B.9
-
9
-
-
0034812659
-
Preclinical studies to predict the disposition of TRAIL in humans: Characterization of in vivo efficacy, pharmacokinetics and safety
-
Kelley SK, Harris LA, Xie D, Deforge L, Totpal K, Bussiere J, Fox JA (2001) Preclinical studies to predict the disposition of TRAIL in humans: Characterization of in vivo efficacy, pharmacokinetics and safety. J Pharmacol Exp Ther 299: 31-38.
-
(2001)
J Pharmacol Exp Ther
, vol.299
, pp. 31-38
-
-
Kelley, S.K.1
Harris, L.A.2
Xie, D.3
Deforge, L.4
Totpal, K.5
Bussiere, J.6
Fox, J.A.7
-
10
-
-
0042878548
-
Protection against collageninduced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist
-
Kim JM, Jeong JG, Ho SH, HahnW, Park EJ, Kim S, Yu SS, Lee YW, Kim S (2003) Protection against collageninduced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist. Gene Ther 10: 1543-1550.
-
(2003)
Gene Ther
, vol.10
, pp. 1543-1550
-
-
Kim, J.M.1
Jeong, J.G.2
Ho, S.H.3
Hahn, W.4
Park, E.J.5
Kim, S.6
Yu, S.S.7
Lee, Y.W.8
Kim, S.9
-
11
-
-
0035050960
-
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
-
Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7: 383-385.
-
(2001)
Nat Med
, vol.7
, pp. 383-385
-
-
Lawrence, D.1
Shahrokh, Z.2
Marsters, S.3
Achilles, K.4
Shih, D.5
Mounho, B.6
Hillan, K.7
Totpal, K.8
DeForge, L.9
Schow, P.10
Hooley, J.11
Sherwood, S.12
-
12
-
-
0033533669
-
Virus treatment questioned after gene therapy death
-
Lehrman S (1999) Virus treatment questioned after gene therapy death. Nature 401: 517-518.
-
(1999)
Nature
, vol.401
, pp. 517-518
-
-
Lehrman, S.1
-
13
-
-
4644352734
-
Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo
-
Ma CH, Zhang Y, Wang XY, Gao LF, Liu H, Guo C, Liu SX, Cao YL, Zhang LN, SunWS (2004) Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo. World J Gastroenterol 10: 2874-2877.
-
(2004)
World J Gastroenterol
, vol.10
, pp. 2874-2877
-
-
Ma, C.H.1
Zhang, Y.2
Wang, X.Y.3
Gao, L.F.4
Liu, H.5
Guo, C.6
Liu, S.X.7
Cao, Y.L.8
Zhang, L.N.9
SunWS10
-
14
-
-
31544466221
-
The importance of abrogation of G2-phase arrest in combined effect of TRAIL and ionizing radiation
-
Rezacova M, Vavrova J, Vokurkova D, Tichy A, Knizek J, Psutka J (2005) The importance of abrogation of G2-phase arrest in combined effect of TRAIL and ionizing radiation. Acta Biochim Polon 52: 889-895.
-
(2005)
Acta Biochim Polon
, vol.52
, pp. 889-895
-
-
Rezacova, M.1
Vavrova, J.2
Vokurkova, D.3
Tichy, A.4
Knizek, J.5
Psutka, J.6
-
15
-
-
0033791244
-
Gene therapy of cancer
-
Rochlitz CF (2000) Gene therapy of cancer. Drugs Today (Barc) 36: 619-629.
-
(2000)
Drugs Today (Barc)
, vol.36
, pp. 619-629
-
-
Rochlitz, C.F.1
-
16
-
-
0346463088
-
Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli
-
Shen YL, Xia XX, Zhang Y, Liu JW, Wei DZ, Yang SL (2003) Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. Biotechnol Lett 25: 2097-2101.
-
(2003)
Biotechnol Lett
, vol.25
, pp. 2097-2101
-
-
Shen, Y.L.1
Xia, X.X.2
Zhang, Y.3
Liu, J.W.4
Wei, D.Z.5
Yang, S.L.6
-
17
-
-
0346146997
-
TRAIL: A potential agent for cancer therapy
-
Shi J, Zheng D, Man K, Fan ST, Xu R (2003) TRAIL: a potential agent for cancer therapy. Curr Mol Med 3: 727-736.
-
(2003)
Curr Mol Med
, vol.3
, pp. 727-736
-
-
Shi, J.1
Zheng, D.2
Man, K.3
Fan, S.T.4
Xu, R.5
-
18
-
-
0032929520
-
Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo
-
Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo. Nat Med 5: 157-163.
-
(1999)
Nat Med
, vol.5
, pp. 157-163
-
-
Walczak, H.1
Miller, R.E.2
Ariail, K.3
Gliniak, B.4
Griffith, T.S.5
Kubin, M.6
Chin, W.7
Jones, J.8
Woodward, A.9
Le, T.10
Smith, C.11
Smolak, P.12
Goodwin, R.G.13
Rauch, C.T.14
Schuh, J.C.15
Lynch, D.H.16
-
19
-
-
15844388108
-
Expression and characterization of human tumor necrosis factor-related apoptosis inducing ligand in methylotrophic yeast Pichia pastoris
-
Wang J, Chen J, Wu M (2004) Expression and characterization of human tumor necrosis factor-related apoptosis inducing ligand in methylotrophic yeast Pichia pastoris. Ital J Biochem 53: 67-72.
-
(2004)
Ital J Biochem
, vol.53
, pp. 67-72
-
-
Wang, J.1
Chen, J.2
Wu, M.3
-
20
-
-
0042882534
-
Expression of a constitutively active mutant of heat shock factor 1 under the control of testis-specific hst70 gene promoter in transgenic mice induces degeneration of seminiferous epithelium
-
Widlak W, Benedyk K, Vydra N, Glowala M, Scieglinska D, Malusecka E, Nakai A, Krawczyk Z (2003) Expression of a constitutively active mutant of heat shock factor 1 under the control of testis-specific hst70 gene promoter in transgenic mice induces degeneration of seminiferous epithelium. Acta Biochim Polon 50: 535-541.
-
(2003)
Acta Biochim Polon
, vol.50
, pp. 535-541
-
-
Widlak, W.1
Benedyk, K.2
Vydra, N.3
Glowala, M.4
Scieglinska, D.5
Malusecka, E.6
Nakai, A.7
Krawczyk, Z.8
-
21
-
-
0017647917
-
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells
-
Wigler M, Silverstein S, Lee LS, Pellicer A, Cheng Y, Axel R (1977) Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11: 223-232.
-
(1977)
Cell
, vol.11
, pp. 223-232
-
-
Wigler, M.1
Silverstein, S.2
Lee, L.S.3
Pellicer, A.4
Cheng, Y.5
Axel, R.6
-
22
-
-
13344285339
-
Identification and characterization of a new member of the TNF family that induces apoptosis
-
Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
-
(1995)
Immunity
, vol.3
, pp. 673-682
-
-
Wiley, S.R.1
Schooley, K.2
Smolak, P.J.3
Din, W.S.4
Huang, C.P.5
Nicholl, J.K.6
Sutherland, G.R.7
Smith, T.D.8
Rauch, C.9
Smith, C.A.10
|